First New York Securities’s GSK GSK Stock Holding History

First New York Securities’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7.7K	Buy	+160	New	+$7.9K	0.01%	69
2014 Q2	–	Sell	-11,280	Closed	-$753K	–	267
2014 Q1	$753K	Buy	+11,280	New	+$763K	0.37%	66

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First New York Securities's GSK Position: Q4 2016 in Review

First New York Securities opened a new position in GSK (GSK) in Q4 2016: 160 shares worth $7.7K. The stake represents 0.01% of the portfolio and ranks #69 among its holdings. This is a return to the name: First New York Securities previously reported a position in GSK as recently as Q1 2014.

First New York Securities first reported a position in GSK in Q1 2014 and has held it in 2 quarters since. The position peaked at $753K in Q1 2014. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

First New York Securities held 160 shares of GSK worth $7.7K as of Q4 2016.
GSK was a new First New York Securities position in Q4 2016.
GSK made up 0.01% of First New York Securities's portfolio in Q4 2016, its #69 holding.
First New York Securities first reported a position in GSK in Q1 2014 and has held it in 2 quarters since.
First New York Securities's GSK position peaked at $753K in Q1 2014.
763 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.